Envisioning Future Therapies for T1D: Where Biology Meets Technology - Tech v. Biology
Presenter: Moshe Phillip, MD (Schneider Children's Medical Center)
Relationship: Commercial Interest(s)
  Advisory Board Member: AstraZeneca
  Advisory Board Member: Eli Lilly & Company
  Advisory Board Member: Insulet Corporation
  Advisory Board Member: Mannkind Corporation
  Advisory Board Member: Medtronic Diabetes
  Advisory Board Member: Pfizer Inc.
  Advisory Board Member: Sanofi
  Advisory Board Member: Other (fill in the blank below)
  Advisory Board Member: DOMPE
  Consulting Fee: Eli Lilly & Company
  Consulting Fee: Medtronic Diabetes
  Consulting Fee: Novo Nordisk
  Consulting Fee: Pfizer Inc.
  Consulting Fee: Sanofi
  Consulting Fee: Other (fill in the blank below)
  Consulting Fee: Qulab Medical
  Grant Recipient: Dexcom
  Grant Recipient: Eli Lilly & Company
  Grant Recipient: Insulet Corporation
  Grant Recipient: Medtronic Diabetes
  Grant Recipient: Novo Nordisk
  Grant Recipient: Pfizer Inc.
  Grant Recipient: Roche Diagnostics
  Grant Recipient: Sanofi
  Grant Recipient: Other (fill in the blank below)
  Grant Recipient: DreaMed-Diabetes, NG Solutions, Dompe, Lumos, GWAVE, OPKO
  Stock Owner: Other (fill in the blank below)
  Stock Owner: DreaMed-Diabetes, NG Solutions

Envisioning Future Therapies for T1D: Where Biology Meets Technology - Modifying stem cell derived beta cell function
Presenter: Matthias Hebrok, PhD (UCSF Diabetes Center)
Relationship: Commercial Interest(s)
  Advisory Board Member: Minutia, Encellin Inc, EndoCrine Biotherapeutics, Thymmune Inc.
  Grant Recipient: Eli Lilly & Company.
  Stock Owner: Viacyte, Minutia, Encellin Inc, EndoCrine Biotherapeutics, Thymmune Inc.

Fred Conrad Koch Lifetime Achievement Award
Presenter: Henry M Kronenberg, MD (Massachusetts Gen Hospital)
No relevant financial relationships

Envisioning Future Therapies for T1D: Where Biology Meets Technology - Presidential Address & Moderator
Presenter: Carol H. Wysham, MD (Rockwood Clinic PS)
Relationship: Commercial Interest(s)
  Grant Recipient: Abbott Laboratories
  Grant Recipient: Corcept
  Grant Recipient: Eli Lilly & Company
  Grant Recipient: Novo Nordisk
  Grant Recipient: Regeneron Pharmaceuticals